Stephen B. Freedman is vice president of corporate liaison and ventures at Gladstone. Through Freedman's leadership, Gladstone has facilitated a number of significant strategic relationships and alliances—across all of Gladstone's research areas—with biotech and pharmaceutical companies, venture capital firms and foundations. Stephen’s team is always looking for new opportunities to advance Gladstone's research through both traditional and non-traditional collaboration models. Stephen has more than 25 years of experience in the pharmaceutical industry, including senior positions at Merck & Co. and Elan Pharmaceuticals. He earned a bachelor's degree in physiology and biochemistry and a PhD in pharmacology from the University of Southampton. He received the G. Kerkut Prize for Physiology in 1978 and completed postdoctoral studies with Professor Richard Miller at the University of Chicago.